Non-endogenous,. constitutively activated human serotonin receptors and small molecule modulators thereof

Details for Australian Patent Application No. 2003257531 (hide)

Owner Arena Pharmaceuticals, Inc. Tripos, Inc.

Inventors Thomsen, William J.; Russo, Joseph F.; Behan, Dominic P .; Chalmers, Derek T.; Foster, Richard J.; Glen, Robert C.; Lawless, Michael S.; Liaw, Chen W.; Liu, Qian; Smith, Julian R.

Agent Watermark

Pub. Number AU-A-2003257531

Parent 764766

Filing date 24 October 2003

Wipo publication date 20 November 2003

International Classifications

C07H 021/04 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 015/63 Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C07K 014/705 Peptides having more than 20 amino acids

C12N 015/09 Mutation or genetic engineering - Recombinant DNA-technology

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

6 November 2003 Complete Application Filed

20 November 2003 Application Open to Public Inspection

  Published as AU-A-2003257531

10 November 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003257532-Cancellation of pilot and unwanted traffic signals in a CDMA system

2003257530-Methods for selectively stimulating proliferation of T cells (D1)